 | • レポートコード：MRC2-11QY01899 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はケトロラクのグローバル市場について調査・分析したレポートです。種類別（テーブル、インジェクション、その他）市場規模、用途別（医療用、化学用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ケトロラクの競争状況、市場シェア ・世界のケトロラク市場：種類別市場規模 2015年-2020年（テーブル、インジェクション、その他） ・世界のケトロラク市場：種類別市場規模予測 2021年-2026年（テーブル、インジェクション、その他） ・世界のケトロラク市場：用途別市場規模 2015年-2020年（医療用、化学用、その他） ・世界のケトロラク市場：用途別市場規模予測 2021年-2026年（医療用、化学用、その他） ・北米のケトロラク市場分析：米国、カナダ ・ヨーロッパのケトロラク市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのケトロラク市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のケトロラク市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのケトロラク市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、DeepCare Health、Cadila、FDC、Intas Laboratories、Gufic Chem、Ranbaxy、Adley Formulation、Neon Laboratories、Sun Pharmaceutical Industries、Cipla、Dallas Pharmaceuticals、Nicholas Piramal India、AHPL ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Ketorolac Market
The global Ketorolac market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ketorolac Scope and Market Size
Ketorolac market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ketorolac market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ketorolac market is segmented into
Tables
Injection
Other
Segment by Application, the Ketorolac market is segmented into
Medical Uses
Chemistry Uses
Other
Regional and Country-level Analysis
The Ketorolac market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ketorolac market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ketorolac Market Share Analysis
Ketorolac market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ketorolac business, the date to enter into the Ketorolac market, Ketorolac product introduction, recent developments, etc.
The major vendors covered:
Allergan
DeepCare Health
Cadila
FDC
Intas Laboratories
Gufic Chem
Ranbaxy
Adley Formulation
Neon Laboratories
Sun Pharmaceutical Industries
Cipla
Dallas Pharmaceuticals
Nicholas Piramal India
AHPL
1 Study Coverage
1.1 Ketorolac Product Introduction
1.2 Market Segments
1.3 Key Ketorolac Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ketorolac Market Size Growth Rate by Type
1.4.2 Tables
1.4.3 Injection
1.4.4 Other
1.5 Market by Application
1.5.1 Global Ketorolac Market Size Growth Rate by Application
1.5.2 Medical Uses
1.5.3 Chemistry Uses
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ketorolac Market Size, Estimates and Forecasts
2.1.1 Global Ketorolac Revenue 2015-2026
2.1.2 Global Ketorolac Sales 2015-2026
2.2 Global Ketorolac, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ketorolac Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ketorolac Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Ketorolac Competitor Landscape by Players
3.1 Ketorolac Sales by Manufacturers
3.1.1 Ketorolac Sales by Manufacturers (2015-2020)
3.1.2 Ketorolac Sales Market Share by Manufacturers (2015-2020)
3.2 Ketorolac Revenue by Manufacturers
3.2.1 Ketorolac Revenue by Manufacturers (2015-2020)
3.2.2 Ketorolac Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ketorolac Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ketorolac Revenue in 2019
3.2.5 Global Ketorolac Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ketorolac Price by Manufacturers
3.4 Ketorolac Manufacturing Base Distribution, Product Types
3.4.1 Ketorolac Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ketorolac Product Type
3.4.3 Date of International Manufacturers Enter into Ketorolac Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ketorolac Market Size by Type (2015-2020)
4.1.1 Global Ketorolac Sales by Type (2015-2020)
4.1.2 Global Ketorolac Revenue by Type (2015-2020)
4.1.3 Ketorolac Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ketorolac Market Size Forecast by Type (2021-2026)
4.2.1 Global Ketorolac Sales Forecast by Type (2021-2026)
4.2.2 Global Ketorolac Revenue Forecast by Type (2021-2026)
4.2.3 Ketorolac Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ketorolac Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Ketorolac Market Size by Application (2015-2020)
5.1.1 Global Ketorolac Sales by Application (2015-2020)
5.1.2 Global Ketorolac Revenue by Application (2015-2020)
5.1.3 Ketorolac Price by Application (2015-2020)
5.2 Ketorolac Market Size Forecast by Application (2021-2026)
5.2.1 Global Ketorolac Sales Forecast by Application (2021-2026)
5.2.2 Global Ketorolac Revenue Forecast by Application (2021-2026)
5.2.3 Global Ketorolac Price Forecast by Application (2021-2026)
6 North America
6.1 North America Ketorolac by Country
6.1.1 North America Ketorolac Sales by Country
6.1.2 North America Ketorolac Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ketorolac Market Facts & Figures by Type
6.3 North America Ketorolac Market Facts & Figures by Application
7 Europe
7.1 Europe Ketorolac by Country
7.1.1 Europe Ketorolac Sales by Country
7.1.2 Europe Ketorolac Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ketorolac Market Facts & Figures by Type
7.3 Europe Ketorolac Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Ketorolac by Region
8.1.1 Asia Pacific Ketorolac Sales by Region
8.1.2 Asia Pacific Ketorolac Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ketorolac Market Facts & Figures by Type
8.3 Asia Pacific Ketorolac Market Facts & Figures by Application
9 Latin America
9.1 Latin America Ketorolac by Country
9.1.1 Latin America Ketorolac Sales by Country
9.1.2 Latin America Ketorolac Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ketorolac Market Facts & Figures by Type
9.3 Central & South America Ketorolac Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Ketorolac by Country
10.1.1 Middle East and Africa Ketorolac Sales by Country
10.1.2 Middle East and Africa Ketorolac Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ketorolac Market Facts & Figures by Type
10.3 Middle East and Africa Ketorolac Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Ketorolac Products Offered
11.1.5 Allergan Related Developments
11.2 DeepCare Health
11.2.1 DeepCare Health Corporation Information
11.2.2 DeepCare Health Description and Business Overview
11.2.3 DeepCare Health Sales, Revenue and Gross Margin (2015-2020)
11.2.4 DeepCare Health Ketorolac Products Offered
11.2.5 DeepCare Health Related Developments
11.3 Cadila
11.3.1 Cadila Corporation Information
11.3.2 Cadila Description and Business Overview
11.3.3 Cadila Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cadila Ketorolac Products Offered
11.3.5 Cadila Related Developments
11.4 FDC
11.4.1 FDC Corporation Information
11.4.2 FDC Description and Business Overview
11.4.3 FDC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 FDC Ketorolac Products Offered
11.4.5 FDC Related Developments
11.5 Intas Laboratories
11.5.1 Intas Laboratories Corporation Information
11.5.2 Intas Laboratories Description and Business Overview
11.5.3 Intas Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Intas Laboratories Ketorolac Products Offered
11.5.5 Intas Laboratories Related Developments
11.6 Gufic Chem
11.6.1 Gufic Chem Corporation Information
11.6.2 Gufic Chem Description and Business Overview
11.6.3 Gufic Chem Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Gufic Chem Ketorolac Products Offered
11.6.5 Gufic Chem Related Developments
11.7 Ranbaxy
11.7.1 Ranbaxy Corporation Information
11.7.2 Ranbaxy Description and Business Overview
11.7.3 Ranbaxy Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ranbaxy Ketorolac Products Offered
11.7.5 Ranbaxy Related Developments
11.8 Adley Formulation
11.8.1 Adley Formulation Corporation Information
11.8.2 Adley Formulation Description and Business Overview
11.8.3 Adley Formulation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Adley Formulation Ketorolac Products Offered
11.8.5 Adley Formulation Related Developments
11.9 Neon Laboratories
11.9.1 Neon Laboratories Corporation Information
11.9.2 Neon Laboratories Description and Business Overview
11.9.3 Neon Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Neon Laboratories Ketorolac Products Offered
11.9.5 Neon Laboratories Related Developments
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Corporation Information
11.10.2 Sun Pharmaceutical Industries Description and Business Overview
11.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sun Pharmaceutical Industries Ketorolac Products Offered
11.10.5 Sun Pharmaceutical Industries Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Ketorolac Products Offered
11.1.5 Allergan Related Developments
11.12 Dallas Pharmaceuticals
11.12.1 Dallas Pharmaceuticals Corporation Information
11.12.2 Dallas Pharmaceuticals Description and Business Overview
11.12.3 Dallas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Dallas Pharmaceuticals Products Offered
11.12.5 Dallas Pharmaceuticals Related Developments
11.13 Nicholas Piramal India
11.13.1 Nicholas Piramal India Corporation Information
11.13.2 Nicholas Piramal India Description and Business Overview
11.13.3 Nicholas Piramal India Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Nicholas Piramal India Products Offered
11.13.5 Nicholas Piramal India Related Developments
11.14 AHPL
11.14.1 AHPL Corporation Information
11.14.2 AHPL Description and Business Overview
11.14.3 AHPL Sales, Revenue and Gross Margin (2015-2020)
11.14.4 AHPL Products Offered
11.14.5 AHPL Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ketorolac Market Estimates and Projections by Region
12.1.1 Global Ketorolac Sales Forecast by Regions 2021-2026
12.1.2 Global Ketorolac Revenue Forecast by Regions 2021-2026
12.2 North America Ketorolac Market Size Forecast (2021-2026)
12.2.1 North America: Ketorolac Sales Forecast (2021-2026)
12.2.2 North America: Ketorolac Revenue Forecast (2021-2026)
12.2.3 North America: Ketorolac Market Size Forecast by Country (2021-2026)
12.3 Europe Ketorolac Market Size Forecast (2021-2026)
12.3.1 Europe: Ketorolac Sales Forecast (2021-2026)
12.3.2 Europe: Ketorolac Revenue Forecast (2021-2026)
12.3.3 Europe: Ketorolac Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ketorolac Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ketorolac Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ketorolac Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ketorolac Market Size Forecast by Region (2021-2026)
12.5 Latin America Ketorolac Market Size Forecast (2021-2026)
12.5.1 Latin America: Ketorolac Sales Forecast (2021-2026)
12.5.2 Latin America: Ketorolac Revenue Forecast (2021-2026)
12.5.3 Latin America: Ketorolac Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ketorolac Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ketorolac Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ketorolac Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ketorolac Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ketorolac Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ketorolac Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Ketorolac Market Segments
Table 2. Ranking of Global Top Ketorolac Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ketorolac Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Tables
Table 5. Major Manufacturers of Injection
Table 6. Major Manufacturers of Other
Table 7. Global Ketorolac Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Ketorolac Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Ketorolac Sales by Regions 2015-2020 (K MT)
Table 10. Global Ketorolac Sales Market Share by Regions (2015-2020)
Table 11. Global Ketorolac Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Ketorolac Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Ketorolac Sales Share by Manufacturers (2015-2020)
Table 14. Global Ketorolac Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Ketorolac by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ketorolac as of 2019)
Table 16. Ketorolac Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Ketorolac Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Ketorolac Price (2015-2020) (USD/MT)
Table 19. Ketorolac Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Ketorolac Product Type
Table 21. Date of International Manufacturers Enter into Ketorolac Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Ketorolac Sales by Type (2015-2020) (K MT)
Table 24. Global Ketorolac Sales Share by Type (2015-2020)
Table 25. Global Ketorolac Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Ketorolac Revenue Share by Type (2015-2020)
Table 27. Ketorolac Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Ketorolac Sales by Application (2015-2020) (K MT)
Table 29. Global Ketorolac Sales Share by Application (2015-2020)
Table 30. North America Ketorolac Sales by Country (2015-2020) (K MT)
Table 31. North America Ketorolac Sales Market Share by Country (2015-2020)
Table 32. North America Ketorolac Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Ketorolac Revenue Market Share by Country (2015-2020)
Table 34. North America Ketorolac Sales by Type (2015-2020) (K MT)
Table 35. North America Ketorolac Sales Market Share by Type (2015-2020)
Table 36. North America Ketorolac Sales by Application (2015-2020) (K MT)
Table 37. North America Ketorolac Sales Market Share by Application (2015-2020)
Table 38. Europe Ketorolac Sales by Country (2015-2020) (K MT)
Table 39. Europe Ketorolac Sales Market Share by Country (2015-2020)
Table 40. Europe Ketorolac Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Ketorolac Revenue Market Share by Country (2015-2020)
Table 42. Europe Ketorolac Sales by Type (2015-2020) (K MT)
Table 43. Europe Ketorolac Sales Market Share by Type (2015-2020)
Table 44. Europe Ketorolac Sales by Application (2015-2020) (K MT)
Table 45. Europe Ketorolac Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Ketorolac Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Ketorolac Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Ketorolac Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Ketorolac Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Ketorolac Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Ketorolac Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Ketorolac Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Ketorolac Sales Market Share by Application (2015-2020)
Table 54. Latin America Ketorolac Sales by Country (2015-2020) (K MT)
Table 55. Latin America Ketorolac Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Ketorolac Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Ketorolac Revenue Market Share by Country (2015-2020)
Table 58. Latin America Ketorolac Sales by Type (2015-2020) (K MT)
Table 59. Latin America Ketorolac Sales Market Share by Type (2015-2020)
Table 60. Latin America Ketorolac Sales by Application (2015-2020) (K MT)
Table 61. Latin America Ketorolac Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Ketorolac Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Ketorolac Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Ketorolac Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Ketorolac Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Ketorolac Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Ketorolac Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Ketorolac Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Ketorolac Sales Market Share by Application (2015-2020)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Major Businesses
Table 72. Allergan Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Allergan Product
Table 74. Allergan Recent Development
Table 75. DeepCare Health Corporation Information
Table 76. DeepCare Health Description and Major Businesses
Table 77. DeepCare Health Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. DeepCare Health Product
Table 79. DeepCare Health Recent Development
Table 80. Cadila Corporation Information
Table 81. Cadila Description and Major Businesses
Table 82. Cadila Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Cadila Product
Table 84. Cadila Recent Development
Table 85. FDC Corporation Information
Table 86. FDC Description and Major Businesses
Table 87. FDC Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. FDC Product
Table 89. FDC Recent Development
Table 90. Intas Laboratories Corporation Information
Table 91. Intas Laboratories Description and Major Businesses
Table 92. Intas Laboratories Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Intas Laboratories Product
Table 94. Intas Laboratories Recent Development
Table 95. Gufic Chem Corporation Information
Table 96. Gufic Chem Description and Major Businesses
Table 97. Gufic Chem Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Gufic Chem Product
Table 99. Gufic Chem Recent Development
Table 100. Ranbaxy Corporation Information
Table 101. Ranbaxy Description and Major Businesses
Table 102. Ranbaxy Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Ranbaxy Product
Table 104. Ranbaxy Recent Development
Table 105. Adley Formulation Corporation Information
Table 106. Adley Formulation Description and Major Businesses
Table 107. Adley Formulation Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Adley Formulation Product
Table 109. Adley Formulation Recent Development
Table 110. Neon Laboratories Corporation Information
Table 111. Neon Laboratories Description and Major Businesses
Table 112. Neon Laboratories Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Neon Laboratories Product
Table 114. Neon Laboratories Recent Development
Table 115. Sun Pharmaceutical Industries Corporation Information
Table 116. Sun Pharmaceutical Industries Description and Major Businesses
Table 117. Sun Pharmaceutical Industries Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Sun Pharmaceutical Industries Product
Table 119. Sun Pharmaceutical Industries Recent Development
Table 120. Cipla Corporation Information
Table 121. Cipla Description and Major Businesses
Table 122. Cipla Ketorolac Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Cipla Product
Table 124. Cipla Recent Development
Table 125. Dallas Pharmaceuticals Corporation Information
Table 126. Dallas Pharmaceuticals Description and Major Businesses
Table 127. Dallas Pharmaceuticals Ketorolac Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Dallas Pharmaceuticals Product
Table 129. Dallas Pharmaceuticals Recent Development
Table 130. Nicholas Piramal India Corporation Information
Table 131. Nicholas Piramal India Description and Major Businesses
Table 132. Nicholas Piramal India Ketorolac Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Nicholas Piramal India Product
Table 134. Nicholas Piramal India Recent Development
Table 135. AHPL Corporation Information
Table 136. AHPL Description and Major Businesses
Table 137. AHPL Ketorolac Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. AHPL Product
Table 139. AHPL Recent Development
Table 140. Global Ketorolac Sales Forecast by Regions (2021-2026) (K MT)
Table 141. Global Ketorolac Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Ketorolac Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Ketorolac Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Ketorolac Sales Forecast by Country (2021-2026) (K MT)
Table 145. North America: Ketorolac Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Ketorolac Sales Forecast by Country (2021-2026) (K MT)
Table 147. Europe: Ketorolac Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Ketorolac Sales Forecast by Region (2021-2026) (K MT)
Table 149. Asia Pacific: Ketorolac Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Ketorolac Sales Forecast by Country (2021-2026) (K MT)
Table 151. Latin America: Ketorolac Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Ketorolac Sales Forecast by Country (2021-2026) (K MT)
Table 153. Middle East and Africa: Ketorolac Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Ketorolac Players
Table 158. Ketorolac Customers List
Table 159. Ketorolac Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Ketorolac Product Picture
Figure 2. Global Ketorolac Sales Market Share by Type in 2020 & 2026
Figure 3. Tables Product Picture
Figure 4. Injection Product Picture
Figure 5. Other Product Picture
Figure 6. Global Ketorolac Sales Market Share by Application in 2020 & 2026
Figure 7. Medical Uses
Figure 8. Chemistry Uses
Figure 9. Other
Figure 10. Ketorolac Report Years Considered
Figure 11. Global Ketorolac Market Size 2015-2026 (US$ Million)
Figure 12. Global Ketorolac Sales 2015-2026 (K MT)
Figure 13. Global Ketorolac Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Ketorolac Sales Market Share by Region (2015-2020)
Figure 15. Global Ketorolac Sales Market Share by Region in 2019
Figure 16. Global Ketorolac Revenue Market Share by Region (2015-2020)
Figure 17. Global Ketorolac Revenue Market Share by Region in 2019
Figure 18. Global Ketorolac Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Ketorolac Revenue in 2019
Figure 20. Ketorolac Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Ketorolac Sales Market Share by Type (2015-2020)
Figure 22. Global Ketorolac Sales Market Share by Type in 2019
Figure 23. Global Ketorolac Revenue Market Share by Type (2015-2020)
Figure 24. Global Ketorolac Revenue Market Share by Type in 2019
Figure 25. Global Ketorolac Market Share by Price Range (2015-2020)
Figure 26. Global Ketorolac Sales Market Share by Application (2015-2020)
Figure 27. Global Ketorolac Sales Market Share by Application in 2019
Figure 28. Global Ketorolac Revenue Market Share by Application (2015-2020)
Figure 29. Global Ketorolac Revenue Market Share by Application in 2019
Figure 30. North America Ketorolac Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Ketorolac Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Ketorolac Sales Market Share by Country in 2019
Figure 33. North America Ketorolac Revenue Market Share by Country in 2019
Figure 34. U.S. Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Ketorolac Market Share by Type in 2019
Figure 39. North America Ketorolac Market Share by Application in 2019
Figure 40. Europe Ketorolac Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Ketorolac Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Ketorolac Sales Market Share by Country in 2019
Figure 43. Europe Ketorolac Revenue Market Share by Country in 2019
Figure 44. Germany Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Ketorolac Market Share by Type in 2019
Figure 55. Europe Ketorolac Market Share by Application in 2019
Figure 56. Asia Pacific Ketorolac Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Ketorolac Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Ketorolac Sales Market Share by Region in 2019
Figure 59. Asia Pacific Ketorolac Revenue Market Share by Region in 2019
Figure 60. China Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Ketorolac Market Share by Type in 2019
Figure 83. Asia Pacific Ketorolac Market Share by Application in 2019
Figure 84. Latin America Ketorolac Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Ketorolac Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Ketorolac Sales Market Share by Country in 2019
Figure 87. Latin America Ketorolac Revenue Market Share by Country in 2019
Figure 88. Mexico Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Ketorolac Market Share by Type in 2019
Figure 95. Latin America Ketorolac Market Share by Application in 2019
Figure 96. Middle East and Africa Ketorolac Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Ketorolac Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Ketorolac Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Ketorolac Revenue Market Share by Country in 2019
Figure 100. Turkey Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Ketorolac Market Share by Type in 2019
Figure 107. Middle East and Africa Ketorolac Market Share by Application in 2019
Figure 108. North America Ketorolac Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Ketorolac Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Ketorolac Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Ketorolac Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Ketorolac Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Ketorolac Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Ketorolac Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Ketorolac Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Ketorolac Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Ketorolac Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
医療用射出成形の世界市場（～2026年） Market Analysis and Insights: Global Medical Injection Molding Market The global Medical Injection Molding market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…- ウォーターマッサージテーブルの世界市場（～2026年） Market Analysis and Insights: Global Water Massage Tables Market The global Water Massage Tables market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Water Massage Tables Scope and Market Size Water Massage Tables market is…
- 無針注射システムの世界市場（～2026年） Needle-free injection systems are used to administer liquid formulations, drugs, and vaccines into patients without piercing the skin with a conventional needle. Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needl…
- デキストロース注射の世界市場（～2026年） Dextrose is also called as glucose as they are chemically identical. It plays a vital role in providing energy to body cells. Dextrose Injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment by a single dose. Route of administration of dextrose injection is intra…
- 屋外用ビリヤード台の世界市場（～2026年） Market Analysis and Insights: Global Outdoor Pool Tables Market The global Outdoor Pool Tables market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Outdoor Pool Tables Scope and Market Size Outdoor Pool Tables market is seg…